Belluscura Share Discussion Threads

[buywell3] 07/1/2022 05:44

A study by the Office for National Statistics (ONS) found around 1.3 million people – equivalent to one in 50 – are likely to be suffering with long-term side effects of the virus.

This includes more than half a million people who first had Covid-19, or suspected they had the virus, at least one year ago.

buywell is of the opinion that this half a million of year long Covid sufferers will quadruple due to the increased transmissibility of omicron meaning 4 to 5 times Delta cases in the coming weeks

dyor

[buywell3] 06/1/2022 17:11

Recent survey indicates 1.3M have long Covid in the UK

36% with breathing difficulty

This survey will not as yet include the tens of millions that are currently acquiring omicron

Another survey in around 6 to 8 weeks time will

[tanners] 05/1/2022 12:15

Hydrus....thanks for posting that link, very useful; and I don't think I've ever seen such consistent glowing reviews about a business as portable oxygen solutions, so clearly a fantastic partner!

[tarrant77] 05/1/2022 11:33

Could be one of the shares of the year in my opinion. Sadly, millions of people world wide will need oxygen support as a result of various medical conditions, before one layers on top the effects of long covid and BELL's product appears to be currently in a class of one. Will be disappointed if the shares do not at least double this year.

[hydrus] 05/1/2022 10:52

Starting to get online reviews now and so far looks very positive. This supplier is highlighting the x-plo2r on their homepage. https://www.portableoxygensolutions.com/belluscura-x-plo2r-portable-oxygen-concentrator/

[buywell3] 04/1/2022 22:14

Unfortunately new mutated strains of covid-19 are starting to appear in France and the USA that have even more mutations than Omicron did

The French one has a rather nasty mutation that Delta had - so it is highly likely imo that DNA from Delta has found its way into Omicron DNA in some people

The extra mutations are thought to mean these new variants could be even more transmissible than Omicron - data from which we should soon start to discover regarding its long covid effects

Not good news imo as many have been rather stupidly saying that Omicron is like a natural vaccine

What omicron is in fact doing is creating a reservoir of Billions of people that are acquire it - that will then go on to create omicron mutations

Unfortunately Delta will be involved in the majority of new mutations

imo dyor

[maytrees] 04/1/2022 08:31

Good morning
Great start so far for BELL. More news very soon I suspect.

[diesel] 30/12/2021 09:03

MT, plus news of follow on model launch!

[maytrees] 30/12/2021 08:52

Good morning buywell2

Their November trading update stated:

The Board expects to update shareholders on the full year outcome for FY21 in early January 2022

So more news very soon.

[buywell2] 30/12/2021 02:57

=============== long COVID and Omicron ===================

More asymptomatic cases seemingly with Omicron but is that good ?

Chest CT Findings in Cases from the Cruise Ship Diamond Princess with Coronavirus Disease (COVID-19)

Asymptomatic cases showed more ground-glass opacity (GGO) predominance over consolidation (83%), while symptomatic cases were more likely to show a consolidation predominance over GGO (41%)




------------------------------------------

Omicron may feel like a common cold, but docs say ‘long COVID’ is still a risk






-------------------------------------------


Mathematical Modeling has predicted that by the end of Feb 2022

3 Billion people could have acquired Omicron with 140M in the USA alone





dyor imo and others

[diesel] 14/12/2021 10:48

This is a one product, one sales territory company at this time, once follow on products and new sales markets are announced this will fly. Early days still, so still a bit risky, but I’m holding for now.

[maytrees] 14/12/2021 10:22

Good morning
The share price fell recently presumably on some profit taking but there is some good buying so far today. I hold; dyor.

[maytrees] 13/12/2021 09:03

Good morning
BELL share price still holding up; probably the good news in USA continues but we shall see.

[maytrees] 10/12/2021 09:12

Good morning
The shortage of stock point made a day or two back may be correct. The BELL share price is so far today, up despite sells.

[diesel] 09/12/2021 14:18

There’s clearly a demand here that’s hard to meet at the mo, not wishing to profit from Covid but recent developments could well be a factor here. They are also due to announce another version this month, with news of marketing approval across new territories could come in anytime now.

[tanners] 09/12/2021 13:23

Not sure whether it's been tipped (again), or something else brewing.....I always feel more confident when rises are news backed, but won't complain!

[maytrees] 09/12/2021 13:09

A couple of minutes after my post above, the offer share price gained slightly

[maytrees] 09/12/2021 12:57

Greetings all
Rather more BELL trades than usual so far today. Presumably if shortage of stock is a problem the share price will not fall in the absence of any large sells and may even gain again.

[tarrant77] 08/12/2021 14:18

Possibly largely technical bounce as little or no trade-but as a decent holder, makes one feel good.

[novandi] 08/12/2021 13:55

Nice bounce in this morning's session, wonder if the momentum will carry through the week?

[maytrees] 08/12/2021 09:36

Greetings pngaseF
Were not warrants converted to new shares only yesterday though?

[maytrees] 08/12/2021 09:35

9.66% now. Is news expected before the new year?

[pngasef] 08/12/2021 09:26

Low volume, MMs must be short on stock.

[diesel] 03/12/2021 09:18

Thanks 20pc, should here some more news soon by that timescale.

[20pc] 02/12/2021 23:34

Diesel... from the final admission document 25/5/21

The Company intends to primarily target the US market, following the launches of the X-PLO2R , X-PLO2R
CX and X-PLO2R DX planned for July 2021, December 2021 and March 2022 respectively. Thereafter, the
Company plans to sell directly to consumers and target international markets from Q1 in 2022. Belluscura
has started the process of seeking the appropriate licenses for distribution in international territories, such
as the CE Mark. The Directors believe these processes will be simplified as the Company has already
received FDA approval.